ID28675A - Komposisi dosis oral pelepasan diperpanjang yang stabil - Google Patents

Komposisi dosis oral pelepasan diperpanjang yang stabil

Info

Publication number: ID28675A
Authority: ID; Indonesia
Prior art keywords: oral; composition; extended stable; displacement; displacement extended
Prior art date: 1999-12-20

Application number

IDP20001115A

Other languages

English (en)

Inventor

Jim H Kou

Original Assignee

Schering Plough Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-20

Filing date

2000-12-20

Publication date

2001-06-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22629437&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID28675(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-12-20 Application filed by Schering Plough Corp filed Critical Schering Plough Corp

2001-06-21 Publication of ID28675A publication Critical patent/ID28675A/id

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Ophthalmology & Optometry (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Toxicology (AREA)
Otolaryngology (AREA)
Immunology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Toys (AREA)
Cosmetics (AREA)

IDP20001115A 1999-12-20 2000-12-20 Komposisi dosis oral pelepasan diperpanjang yang stabil ID28675A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US17283699P	1999-12-20	1999-12-20

Publications (1)

Publication Number	Publication Date
ID28675A true ID28675A (id)	2001-06-21

Family

ID=22629437

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDP20001115A ID28675A (id)	1999-12-20	2000-12-20	Komposisi dosis oral pelepasan diperpanjang yang stabil

Country Status (38)

Country	Link
US (2)	US6979463B2 (id)
EP (2)	EP1112738B1 (id)
JP (3)	JP5042403B2 (id)
KR (2)	KR100936572B1 (id)
CN (3)	CN101081224B (id)
AR (1)	AR027033A1 (id)
AT (1)	ATE463240T1 (id)
AU (4)	AU2277101A (id)
BR (1)	BR0006403A (id)
CA (1)	CA2329217C (id)
CO (1)	CO5251435A1 (id)
CY (1)	CY1110693T1 (id)
CZ (1)	CZ302860B6 (id)
DE (1)	DE60044117D1 (id)
DK (1)	DK1112738T3 (id)
EC (1)	ECSP003836A (id)
EG (1)	EG23759A (id)
ES (1)	ES2341751T3 (id)
HK (1)	HK1034453A1 (id)
HU (1)	HUP0004988A3 (id)
ID (1)	ID28675A (id)
IL (1)	IL140450A (id)
MX (1)	MXPA00013037A (id)
MY (1)	MY130773A (id)
NO (1)	NO331645B1 (id)
NZ (1)	NZ509028A (id)
PE (1)	PE20010982A1 (id)
PL (1)	PL211573B1 (id)
PT (1)	PT1112738E (id)
RU (2)	RU2303440C2 (id)
SA (2)	SA06270069B1 (id)
SG (1)	SG109438A1 (id)
SI (1)	SI1112738T1 (id)
SK (1)	SK287684B6 (id)
TR (1)	TR200003787A3 (id)
TW (1)	TWI225414B (id)
WO (1)	WO2001045668A2 (id)
ZA (1)	ZA200007715B (id)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001045676A2 (en)	1999-12-20	2001-06-28	Schering Corporation	Extended release oral dosage composition
SK287684B6 (sk)	1999-12-20	2011-06-06	Schering Corporation	Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
US7405223B2 (en)	2000-02-03	2008-07-29	Schering Corporation	Treating allergic and inflammatory conditions
US20030070584A1 (en)	2001-05-15	2003-04-17	Cynthia Gulian	Dip coating compositions containing cellulose ethers
BR0210534A (pt) *	2001-06-20	2004-06-22	Schering Corp	Anti-histaminas para o tratamento de congestão nasal e obstrução nasal
US8309118B2 (en)	2001-09-28	2012-11-13	Mcneil-Ppc, Inc.	Film forming compositions containing sucralose
NZ535455A (en) *	2002-02-21	2009-08-28	Biovail Lab Int Srl	Controlled release dosage forms
US8323692B2 (en)	2002-02-21	2012-12-04	Valeant International Bermuda	Controlled release dosage forms
PT1507531E (pt) *	2003-03-12	2007-03-30	Teva Pharma	Composições farmacêuticas estáveis de desloratadina
US20050013863A1 (en)	2003-07-18	2005-01-20	Depomed, Inc., A Corporation Of The State Of California	Dual drug dosage forms with improved separation of drugs
JP4999329B2 (ja) *	2003-12-01	2012-08-15	武田薬品工業株式会社	固形製剤の印刷前処理方法
CA2585122A1 (en) *	2004-10-25	2006-05-04	Schering Corporation	M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders
US20060252830A1 (en) *	2005-05-06	2006-11-09	Brandon Stephen F	Method for the treatment of magnesium and potassium deficiencies
US20060252831A1 (en) *	2005-05-06	2006-11-09	Christopher Offen	Method for the treatment of magnesium and potassium deficiencies
US20070014855A1 (en) *	2005-07-12	2007-01-18	Rahul Gawande S	Stable desloratadine compositions
US20070036859A1 (en) *	2005-08-11	2007-02-15	Perry Ronald L	Sustained release antihistamine and decongestant composition
US7827042B2 (en)	2005-11-30	2010-11-02	The Invention Science Fund I, Inc	Methods and systems related to transmission of nutraceutical associated information
US7927787B2 (en)	2006-06-28	2011-04-19	The Invention Science Fund I, Llc	Methods and systems for analysis of nutraceutical associated components
US10296720B2 (en)	2005-11-30	2019-05-21	Gearbox Llc	Computational systems and methods related to nutraceuticals
US8297028B2 (en)	2006-06-14	2012-10-30	The Invention Science Fund I, Llc	Individualized pharmaceutical selection and packaging
US8000981B2 (en)	2005-11-30	2011-08-16	The Invention Science Fund I, Llc	Methods and systems related to receiving nutraceutical associated information
US8068991B2 (en)	2005-11-30	2011-11-29	The Invention Science Fund I, Llc	Systems and methods for transmitting pathogen related information and responding
US7974856B2 (en)	2005-11-30	2011-07-05	The Invention Science Fund I, Llc	Computational systems and methods related to nutraceuticals
US8340944B2 (en)	2005-11-30	2012-12-25	The Invention Science Fund I, Llc	Computational and/or control systems and methods related to nutraceutical agent selection and dosing
FR2894143B1 (fr)	2005-12-01	2008-05-02	Pierre Fabre Medicament Sa	Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation.
AR061166A1 (es) *	2006-06-01	2008-08-06	Schering Corp	Composiciones farmaceuticas para la liberacion sostenida de fenilferina
PL2034970T3 (pl) *	2006-06-01	2012-12-31	Msd Consumer Care Inc	Preparat farmaceutyczny o przedłużonym uwalnianiu zawierający fenylefrynę
NZ573174A (en) *	2006-06-01	2012-01-12	Msd Consumer Care Inc	Sustained release pharmaceutical dosage form containing phenylephrine
RU2008151945A (ru) *	2006-06-01	2010-07-20	Шеринг Корпорейшн (US)	Лекарственные формы с пульсирующим высвобождением и фармацевтические композиции фенилэфрина
WO2008008434A1 (en) *	2006-07-11	2008-01-17	Mutual Pharmaceutical Company, Inc.	Controlled-release formulations
US20080299186A1 (en) *	2007-06-01	2008-12-04	Schering-Plough Healthcare Products, Inc.	Coatings for applying substances onto substrate carrier
PE20091084A1 (es) *	2007-12-07	2009-07-23	Schering Plough Healthcare	Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
WO2010099508A1 (en)	2009-02-26	2010-09-02	Theraquest Biosciences, Inc.	Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
WO2010143202A1 (en) *	2009-06-09	2010-12-16	Sun Pharmaceutical Industries Ltd.	Pharmaceutical composition
TR201009396A2 (tr)	2010-11-11	2012-05-21	Bi̇lgi̇ç Mahmut	Desloratadin granüller
DE102016107760B4 (de) *	2016-04-26	2018-09-20	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Essbare Funktionsschichten und Überzüge auf Hybridpolymerbasis für Pharmazie und Lebensmittel
US10463656B2 (en)	2017-01-05	2019-11-05	Iowa State University Research Foundation, Inc.	Methods and compositions for prevention of feedlot bovine respiratory disease
CR20230109A (es)	2020-07-30	2023-05-11	Faes Farma Sa	Sistema de liberación de fármacos descongestivos y bilastina

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US100000A (en)		1870-02-22		Improved sun-bonnet for horses
US3536809A (en)	1969-02-17	1970-10-27	Alza Corp	Medication method
US3598123A (en)	1969-04-01	1971-08-10	Alza Corp	Bandage for administering drugs
US3845770A (en)	1972-06-05	1974-11-05	Alza Corp	Osmatic dispensing device for releasing beneficial agent
US3916899A (en)	1973-04-25	1975-11-04	Alza Corp	Osmotic dispensing device with maximum and minimum sizes for the passageway
US3940485A (en)	1973-12-12	1976-02-24	Levinson Harold N	Treatment and pre-treatment of dysmetric dyslexia by improving sequential scanning and ocular fixation abilities and therapeutic compounds
US4008796A (en)	1974-03-26	1977-02-22	General Concrete Of Canada Limited	Control method for feeding items on a conveyor
GB1548022A (en)	1976-10-06	1979-07-04	Wyeth John & Brother Ltd	Pharmaceutial dosage forms
US4282233B1 (en)	1980-06-19	2000-09-05	Schering Corp	Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
HU194864B (en)	1984-02-15	1988-03-28	Schering Corp	Process for production of 8-chlor-6,11-dihydro-11-(4-piperidilidene)-5h-benzo (5,6)-cyclo-hepta (1,2-b) pyridine and its salts
US4552899A (en)	1984-04-09	1985-11-12	Analgesic Associates	Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en)	1984-04-09	1988-11-08	Analgesic Associates	Cough/cold mixtures comprising non-sedating antihistamine drugs
SE8404467D0 (sv)	1984-09-06	1984-09-06	Ferrosan Ab	Controlled-release medical preparations
US4731447A (en)	1985-05-13	1988-03-15	Schering Corporation	Process for preparing piperidylidene dihydro-dibenzo(a,d)-cycloheptenes or aza-derivatives thereof
US4804666A (en)	1985-08-14	1989-02-14	Schering Corporation	Antiallergic 6,11-dihydro-11-(4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines
JPS6396126A (ja) *	1986-10-13	1988-04-27	Taisho Pharmaceut Co Ltd	安定化組成物
US5089496A (en) *	1986-10-31	1992-02-18	Schering Corporation	Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US4777170A (en)	1987-02-03	1988-10-11	Heinrich William A	Method to prevent and treat the signs and symptoms of motion sickness
GB8707421D0 (en) *	1987-03-27	1987-04-29	Wellcome Found	Pharmaceutical formulations
US4863931A (en) *	1988-09-15	1989-09-05	Schering Corporation	Antihistaminic fluoro substituted benzocycloheptapyridines
US5019591A (en) *	1989-02-17	1991-05-28	Pennsylvania Research Corporation	Method for treating retinopathy and other small vessel disorders associated with diabetes
US4990535A (en) *	1989-05-03	1991-02-05	Schering Corporation	Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
NZ238629A (en)	1990-06-22	1993-09-27	Schering Corp	Bis-benzo- or benzopyrido-cyclohepta (where z is c, o, s or n) piperidine, piperidylidene or piperazine compounds, medicaments and methods of preparation
JPH06504772A (ja)	1990-12-18	1994-06-02	ザ　ウエルカム　ファウンデーション　リミテッド	抗癌剤の薬効を増強し抗多剤耐性を有する薬剤
MX9202350A (es)	1991-05-20	1992-11-01	Alza Corp	Composiciones de incrementador de penetracion a la piel que usan monolinoleato de glicerol.
YU48263B (sh)	1991-06-17	1997-09-30	Byk Gulden Lomberg Chemische Fabrik Gmbh.	Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
US5266331A (en)	1991-11-27	1993-11-30	Euroceltique, S.A.	Controlled release oxycodone compositions
ES2042421B1 (es)	1992-05-22	1994-08-01	Uriach & Cia Sa J	Procedimiento para la obtencion de la 8-cloro-11-1-(5-metil-3-piridil)metil-4-piperidiliden-6,11-dihidro-5h-benzo5,6ciclohepta1,2-bpiridina.
US5314697A (en)	1992-10-23	1994-05-24	Schering Corporation	Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
IT1264517B1 (it)	1993-05-31	1996-09-24	Ekita Investments Nv	Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
JP2646972B2 (ja)	1993-11-01	1997-08-27	日本電気株式会社	多ビットメモリ
DE4442999A1 (de)	1994-12-02	1996-06-05	Hexal Pharma Gmbh	Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
US5595997A (en) *	1994-12-30	1997-01-21	Sepracor Inc.	Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
US5807579A (en) *	1995-11-16	1998-09-15	F.H. Faulding & Co. Limited	Pseudoephedrine combination pharmaceutical compositions
CN1235545A (zh) *	1996-10-31	1999-11-17	先灵公司	含有氯雷他定和减充血剂的用于治疗哮喘的组合物
PE71699A1 (es) *	1997-02-07	1999-08-03	Sepracor Inc	Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
US5900421A (en) *	1997-02-11	1999-05-04	Sepracor Inc.	Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
US5939426A (en) *	1997-02-28	1999-08-17	Sepracor Inc.	Methods for treating urinary incontinence using descarboethoxyloratadine
US6506767B1 (en) *	1997-07-02	2003-01-14	Schering Corporation	8-chloro-6,11-dihydro-11-(4-piperidylidine)-5H-benzo[5,6]cyclohepta[1-2-b] pyridine
EP1032392A4 (en) *	1997-10-29	2001-05-09	J Med Pharmaceuticals Inc	RHINITIS TREATMENT BY ANTIHISTAMINE / DECONGESTIVUM ADMINISTRATION
US6132758A (en) *	1998-06-01	2000-10-17	Schering Corporation	Stabilized antihistamine syrup
WO2000002560A1 (en)	1998-07-10	2000-01-20	Schering Corporation	8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDINE ORAL COMPOSITIONS
US6423721B1 (en)	1998-09-10	2002-07-23	Schering Corporation	Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
US6051585A (en) *	1998-12-07	2000-04-18	Weinstein; Robert E.	Single-dose antihistamine/decongestant formulations for treating rhinitis
US6521254B2 (en) *	1998-12-07	2003-02-18	J-Med Pharmaceuticals, Inc.	Single-dose antihistamine/decongestant formulations for treating rhinitis
US6100274A (en)	1999-07-07	2000-08-08	Schering Corporation	8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US6114346A (en) *	1999-10-22	2000-09-05	Schering Corporation	Treating sleep disorders using desloratadine
SK287684B6 (sk)	1999-12-20	2011-06-06	Schering Corporation	Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
WO2001045676A2 (en)	1999-12-20	2001-06-28	Schering Corporation	Extended release oral dosage composition
US7405223B2 (en)	2000-02-03	2008-07-29	Schering Corporation	Treating allergic and inflammatory conditions
CN1213752C (zh)	2000-02-03	2005-08-10	先灵公司	变应性和炎性疾病的治疗
ATE272619T1 (de)	2000-05-19	2004-08-15	Alcon Inc	Anilin-disulfid-derivate zur behandlung allergischer erkrankungen
US6599913B1 (en)	2001-06-29	2003-07-29	Schering Corporation	Treating allergic and inflammatory conditions

2000
- 2000-12-19 SK SK1967-2000A patent/SK287684B6/sk not_active IP Right Cessation
- 2000-12-19 AU AU22771/01A patent/AU2277101A/en not_active Abandoned
- 2000-12-19 WO PCT/US2000/034412 patent/WO2001045668A2/en active Application Filing
- 2000-12-20 SI SI200031059T patent/SI1112738T1/sl unknown
- 2000-12-20 CN CN2006100944812A patent/CN101081224B/zh not_active Expired - Fee Related
- 2000-12-20 CN CNB001373005A patent/CN1211079C/zh not_active Expired - Fee Related
- 2000-12-20 ES ES00311445T patent/ES2341751T3/es not_active Expired - Lifetime
- 2000-12-20 KR KR1020000079045A patent/KR100936572B1/ko not_active IP Right Cessation
- 2000-12-20 PE PE2000001371A patent/PE20010982A1/es not_active Application Discontinuation
- 2000-12-20 MX MXPA00013037A patent/MXPA00013037A/es active IP Right Grant
- 2000-12-20 MY MYPI20005989A patent/MY130773A/en unknown
- 2000-12-20 NO NO20006504A patent/NO331645B1/no not_active IP Right Cessation
- 2000-12-20 CN CNA2005100713014A patent/CN1679569A/zh active Pending
- 2000-12-20 DK DK00311445.1T patent/DK1112738T3/da active
- 2000-12-20 PL PL344715A patent/PL211573B1/pl not_active IP Right Cessation
- 2000-12-20 EG EG20001571A patent/EG23759A/xx active
- 2000-12-20 JP JP2000387828A patent/JP5042403B2/ja not_active Expired - Fee Related
- 2000-12-20 CO CO00096727A patent/CO5251435A1/es active IP Right Grant
- 2000-12-20 CA CA002329217A patent/CA2329217C/en not_active Expired - Fee Related
- 2000-12-20 AR ARP000106790A patent/AR027033A1/es not_active Application Discontinuation
- 2000-12-20 TW TW089127375A patent/TWI225414B/zh not_active IP Right Cessation
- 2000-12-20 EC EC2000003836A patent/ECSP003836A/es unknown
- 2000-12-20 NZ NZ509028A patent/NZ509028A/xx not_active IP Right Cessation
- 2000-12-20 AU AU72443/00A patent/AU781924B2/en not_active Ceased
- 2000-12-20 DE DE60044117T patent/DE60044117D1/de not_active Expired - Lifetime
- 2000-12-20 HU HU0004988A patent/HUP0004988A3/hu unknown
- 2000-12-20 EP EP00311445A patent/EP1112738B1/en not_active Expired - Lifetime
- 2000-12-20 SG SG200007531A patent/SG109438A1/en unknown
- 2000-12-20 IL IL140450A patent/IL140450A/en not_active IP Right Cessation
- 2000-12-20 AT AT00311445T patent/ATE463240T1/de active
- 2000-12-20 CZ CZ20004812A patent/CZ302860B6/cs not_active IP Right Cessation
- 2000-12-20 PT PT00311445T patent/PT1112738E/pt unknown
- 2000-12-20 BR BR0006403-3A patent/BR0006403A/pt not_active Application Discontinuation
- 2000-12-20 RU RU2000131898/15A patent/RU2303440C2/ru not_active IP Right Cessation
- 2000-12-20 TR TR2000/03787A patent/TR200003787A3/tr unknown
- 2000-12-20 ID IDP20001115A patent/ID28675A/id unknown
- 2000-12-20 EP EP10159005A patent/EP2196195A3/en not_active Withdrawn
- 2000-12-20 ZA ZA200007715A patent/ZA200007715B/xx unknown
2001
- 2001-02-25 SA SA06270069A patent/SA06270069B1/ar unknown
- 2001-02-25 SA SA01210741A patent/SA01210741B1/ar unknown
- 2001-07-19 HK HK01105066.7A patent/HK1034453A1/xx not_active IP Right Cessation
2002
- 2002-06-19 US US10/175,460 patent/US6979463B2/en not_active Expired - Lifetime
2005
- 2005-08-22 AU AU2005203771A patent/AU2005203771A1/en not_active Abandoned
- 2005-10-06 US US11/244,743 patent/US7820199B2/en not_active Expired - Fee Related
2007
- 2007-02-02 RU RU2007104095/15A patent/RU2423106C9/ru not_active IP Right Cessation
- 2007-12-14 JP JP2007324054A patent/JP2008081510A/ja active Pending
2009
- 2009-02-06 AU AU2009200460A patent/AU2009200460B2/en not_active Ceased
2010
- 2010-06-07 CY CY20101100503T patent/CY1110693T1/el unknown
2011
- 2011-02-23 KR KR1020110016213A patent/KR101234940B1/ko not_active IP Right Cessation
2012
- 2012-08-17 JP JP2012181028A patent/JP2012224642A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
CO5251435A1 (es)	2003-02-28
HU0004988D0 (id)	2001-02-28
PL344715A1 (en)	2001-07-02
ES2341751T3 (es)	2010-06-28
SG109438A1 (en)	2005-03-30
AU2277101A (en)	2001-07-03
EP2196195A2 (en)	2010-06-16
HUP0004988A3 (en)	2008-04-28
AU781924B2 (en)	2005-06-23
WO2001045668A2 (en)	2001-06-28
ECSP003836A (es)	2002-02-25
MXPA00013037A (es)	2003-06-19
MY130773A (en)	2007-07-31
PT1112738E (pt)	2010-06-04
SA01210741A (ar)	2005-12-03
NZ509028A (en)	2002-12-20
BR0006403A (pt)	2001-07-17
AU7244300A (en)	2001-06-21
ZA200007715B (en)	2001-06-20
AU2009200460B2 (en)	2012-01-19
EP1112738A3 (en)	2001-07-18
PL211573B1 (pl)	2012-05-31
JP2001172174A (ja)	2001-06-26
KR101234940B1 (ko)	2013-02-19
KR20010062542A (ko)	2001-07-07
DK1112738T3 (da)	2010-06-28
AU2009200460A1 (en)	2009-02-26
KR100936572B1 (ko)	2010-01-13
CA2329217C (en)	2006-10-31
AR027033A1 (es)	2003-03-12
JP2008081510A (ja)	2008-04-10
CY1110693T1 (el)	2015-06-10
RU2423106C9 (ru)	2012-06-27
SI1112738T1 (sl)	2010-07-30
CN101081224B (zh)	2012-05-30
US7820199B2 (en)	2010-10-26
IL140450A (en)	2011-11-30
EP2196195A3 (en)	2012-02-29
DE60044117D1 (de)	2010-05-20
US20030086971A1 (en)	2003-05-08
US6979463B2 (en)	2005-12-27
RU2303440C2 (ru)	2007-07-27
JP5042403B2 (ja)	2012-10-03
CN1679569A (zh)	2005-10-12
TR200003787A2 (tr)	2001-07-23
AU2005203771A1 (en)	2005-09-15
EP1112738A2 (en)	2001-07-04
NO20006504L (no)	2001-06-21
EP1112738B1 (en)	2010-04-07
CA2329217A1 (en)	2001-06-20
NO20006504D0 (no)	2000-12-20
KR20110028326A (ko)	2011-03-17
TWI225414B (en)	2004-12-21
SK287684B6 (sk)	2011-06-06
SK19672000A3 (sk)	2001-09-11
CZ20004812A3 (cs)	2001-08-15
CZ302860B6 (cs)	2011-12-21
SA01210741B1 (ar)	2006-10-31
HK1034453A1 (en)	2001-10-26
NO331645B1 (no)	2012-02-13
WO2001045668A3 (en)	2001-12-13
RU2007104095A (ru)	2008-08-10
JP2012224642A (ja)	2012-11-15
CN1301534A (zh)	2001-07-04
HUP0004988A2 (hu)	2002-11-28
SA06270069B1 (ar)	2009-06-07
ATE463240T1 (de)	2010-04-15
RU2423106C2 (ru)	2011-07-10
TR200003787A3 (tr)	2001-07-23
CN101081224A (zh)	2007-12-05
IL140450A0 (en)	2002-02-10
EG23759A (en)	2007-08-08
CN1211079C (zh)	2005-07-20
PE20010982A1 (es)	2001-09-28
US20060159761A1 (en)	2006-07-20

Publication	Publication Date	Title
ID28675A (id)	2001-06-21	Komposisi dosis oral pelepasan diperpanjang yang stabil
ID29468A (id)	2001-08-30	Komposisi farmasi yang stabil dalam bentuk liofil
CY2007031I1 (el)	2009-11-04	Συνθεση στοματικης δοσολογιας παρατεταμενης απελευθερωσης
HK1088546A1 (en)	2006-11-10	Stable oral care compositions comprising chlorite
FI991485A (fi)	2000-12-31	Uusi farmaseuttinen koostumus
IS2325B (is)	2007-12-15	Örgerðar samsetningar epleróns
EE200200393A (et)	2003-10-15	Glüburiidi ravimkoostis
DE60008422D1 (de)	2004-03-25	Pour-on formulierungen
NO20020185D0 (no)	2002-01-14	Formuleringer av IL-11
HUP0203311A2 (hu)	2004-05-28	Új nyújtott hatású gyógyszerkészítmények
ITMI982222A0 (it)	1998-10-16	Composizioni farmaceutiche orali contenenti buprenorfina
NO20015670D0 (no)	2001-11-20	Forbedrede farmasöytiske formuleringer
ID30226A (id)	2001-11-15	Komposisi penat rambut
DE60037014D1 (de)	2007-12-20	Kosmetische zusammensetzungen enthaltend polysaccharid-sterol-derivate
ATE383156T1 (de)	2008-01-15	Oral verabreichbare zusammensetzung enthaltend parecoxib
IS6021A (is)	2001-10-20	Lyfjasamsetningar sem innihalda sítalópram
ATE270107T1 (de)	2004-07-15	Ciclesonidhaltige wässrige arzneizusammensetzungen
LU90483B1 (fr)	2001-01-31	Compositions nouvelles de m-thanesulfonate de parox-tine
DK1216032T3 (da)	2008-06-02	Orale formuleringer med kontrolleret frigivelse
ID30397A (id)	2001-11-29	Larutan oral prukaloprida
EE200200213A (et)	2003-06-16	Suukaudselt manustatav galantamiinilahus
NO20003799L (no)	2001-01-29	Innkorporering av kolesterol senkende midler i konfekt- dosisformer
EE200100381A (et)	2002-12-16	Morfolinobensamiidi uued soolad
EE200300434A (et)	2003-12-15	Farmatseutiliselt toimivate ühendite kasutamine
HUP0203900A3 (en)	2005-06-28	Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments